GLP-1 Weight-Loss Drugs Create Opportunities for Indian Pharma

Indian pharmaceutical companies like Cipla and Dr Reddy's Laboratories are positioning themselves to capitalize on the emerging weight-loss drug market in India, which presents a growth opportunity for their domestic business. This expansion comes as these firms navigate challenging conditions in the US pharmaceutical market. The GLP-1 drug category is expected to provide a significant revenue boost for Indian pharma companies in their home market.